Eli Lilly shares rise 3.2% to $1,139 in market quote
The move comes as investors track the incretin leader's position in the obesity and diabetes drug market.
TR
By Tom Reyes · Markets Editor
Sep 16 07:46 ETSource: TradingKey
The wire
- 01Eli Lilly stock was quoted at $1,139.28, up 3.17%.
- 02Lilly's valuation is closely tied to demand for its GLP-1 franchise.
- 03No company announcement was cited as the driver of the move.
From the source
Read at news.google.comLLY|Eli Lilly and Co|Price:1139.280|Chg%:+3.170